Pharmaceutical company Hypera reported Wednesday that it expects net profit from continuing operations of about 1.85 billion reais in 2024, according to projections released to the market.
The company also expects adjusted EBITDA from continuing operations of approximately 3 billion reais in the period, per relevant fact, and net sales of approximately 8.6 billion reais.
Hypera underlined that the net profit projection considers the current scenario of expected interest rates for 2024.
Source: Terra
Rose James is a Gossipify movie and series reviewer known for her in-depth analysis and unique perspective on the latest releases. With a background in film studies, she provides engaging and informative reviews, and keeps readers up to date with industry trends and emerging talents.
